Childhood Cancer Incidence, New York State, 2010-2014

Source: New York State Cancer Registry

Site of Cancer Ages 0-4 Ages 5-9 Ages 10-14 Ages 15-19 Combined Ages 0-14 Combined Ages 0-19
Avg Annual Cases Rate per 1,000,000 Avg Annual Cases Rate per 1,000,000 Avg Annual Cases Rate per 1,000,000 Avg Annual Cases Rate per 1,000,000 Avg Annual Cases Rate per 1,000,000 95% CI (+/-) Avg Annual Cases Rate per 1,000,000 95% CI (+/-)
All Invasive Malignant Tumors 281.6 240.3 166.2 144.1 204.6 171.8 346.4 264.3 652.4 184.4 6.3 998.8 204.5 5.7
I Leukemias 97.4 83.1 59.8 51.9 43.2 36.3 49.0 37.4 200.4 56.7 3.5 249.4 51.8 2.9
   I(a) Lymphoid leukemias 73.0 62.3 49.2 42.7 25.4 21.3 20.8 15.9 147.6 41.8 3.0 168.4 35.3 2.4
   I(b) Acute myeloid leukemia 14.0 11.9 5.8 5.0 9.6 8.1 15.6 11.9 29.4 8.3 1.3 45.0 9.2 1.2
II Lymphomas and reticuloendothelial neoplasms 23.6 20.1 23.2 20.1 41.4 34.8 83.2 63.5 88.2 25.1 2.3 171.4 34.8 2.3
   II(a) Hodgkin lymphoma 0.8 0.7 4.2 3.6 17.0 14.3 52.6 40.1 22.0 6.3 1.2 74.6 14.8 1.5
   II(b,c,d) Non-Hodgkin lymphomas 22.8 19.5 18.8 16.3 24.2 20.3 29.0 22.1 65.8 18.7 2.0 94.8 19.6 1.8
III CNS & misc intracranial & intraspinal neoplasms 50.4 43.0 43.0 37.3 40.6 34.1 35.8 27.3 134.0 38.1 2.9 169.8 35.4 2.4
   III(a) Ependymomas and choroid plexus tumor 4.8 4.1 3.4 2.9 3.6 3.0 3.2 2.4 11.8 3.3 0.9 15.0 3.1 0.7
   III(b) Astrocytoma 27.6 23.6 25.0 21.7 23.0 19.3 21.6 16.5 75.6 21.5 2.2 97.2 20.2 1.8
   III(c) Intracranial and intraspinal embryonal tum 12.0 10.2 7.2 6.2 4.6 3.9 3.0 2.3 23.8 6.7 1.2 26.8 5.6 1.0
   III(d) Other gliomas 4.6 3.9 6.6 5.7 7.0 5.9 6.8 5.2 18.2 5.2 1.1 25.0 5.2 0.9
IV Neuroblastoma and other peripheral nervous cell tumors 32.0 27.3 5.6 4.9 2.0 1.7 1.0 0.8 39.6 11.0 1.5 40.6 8.4 1.2
   IV(a) Neuroblastoma and ganglioneuroblastoma 31.8 27.1 5.4 4.7 1.6 1.3 0.2 0.2 38.8 10.7 1.5 39.0 8.1 1.1
V Retinoblastoma 19.2 16.4 0.4 0.3 0.0 0.0 0.0 0.0 19.6 5.4 1.1 19.6 4.0 0.8
VI Renal tumors 24.2 20.6 5.8 5.0 2.0 1.7 2.2 1.7 32.0 8.9 1.4 34.2 7.1 1.1
   VI(a) Nephroblastoma and other nonepithelial rena 24.2 20.6 5.8 5.0 0.4 0.3 0.6 0.5 30.4 8.5 1.3 31.0 6.4 1.0
VII Hepatic tumors 7.2 6.1 1.2 1.0 1.4 1.2 2.8 2.1 9.8 2.7 0.8 12.6 2.6 0.6
   VII(a) Hepatoblastoma 6.8 5.8 0.6 0.5 0.2 0.2 0.0 0.0 7.6 2.1 0.7 7.6 1.6 0.5
VIII Malignant bone tumors 0.6 0.5 6.8 5.9 19.6 16.5 21.4 16.3 27.0 7.8 1.3 48.4 9.9 1.3
   VIII(a) Osteosarcoma 0.0 0.0 2.6 2.3 12.8 10.7 11.2 8.5 15.4 4.4 1.0 26.6 5.5 0.9
   VIII(c) Ewing tumor and related sarcomas of bone 0.6 0.5 3.8 3.3 5.4 4.5 7.0 5.3 9.8 2.8 0.8 16.8 3.5 0.7
IX Soft tissue and other extraosseous sarcomas 15.4 13.1 12.4 10.8 17.0 14.3 19.2 14.7 44.8 12.7 1.7 64.0 13.2 1.4
   IX(a) Rhabdomyosarcoma 10.0 8.5 6.2 5.4 4.0 3.4 3.8 2.9 20.2 5.7 1.1 24.0 5.0 0.9
X Germ cell & trophoblastic tumors & gonadal neoplasms 7.4 6.3 3.8 3.3 12.4 10.4 36.6 27.9 23.6 6.7 1.2 60.2 12.0 1.4
   X(a) Intracranial and intraspinal germ cell tumo 0.2 0.2 1.6 1.4 5.0 4.2 3.0 2.3 6.8 2.0 0.7 9.8 2.0 0.6
   X(c) Malignant gonadal germ cell tumor 1.6 1.4 2.0 1.7 6.6 5.5 28.0 21.4 10.2 2.9 0.8 38.2 7.6 1.1
XI Other malignant epithelial neoplasms and malignant melanomas 2.4 2.0 4.2 3.6 24.4 20.5 93.4 71.3 31.0 8.9 1.4 124.4 24.6 1.9
   XI(b) Thyroid carcinoma 0.4 0.3 1.6 1.4 10.6 8.9 52.2 39.8 12.6 3.6 0.9 64.8 12.7 1.4
   XI(d) Malignant melanoma 1.6 1.4 1.4 1.2 5.0 4.2 15.4 11.8 8.0 2.3 0.7 23.4 4.7 0.8
XII Other and unspecified malignant neoplasms 1.4 1.2 0.0 0.0 0.4 0.3 1.2 0.9 1.8 0.5 0.3 3.0 0.6 0.3

Notes

  • Incidence data are provisional, November 2016.
  • Rates are per 1,000,000 children. Rates for 0-14 and 0-19 year age intervals are age-adjusted within these intervals to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases per year are unstable and should be used with caution.
  • Non-Hodgkin lymphomas, Burkitt, and miscellaneous lymphomas are grouped together under II(b,c,d).